Amesite Operating Co Stock price
$0.91
-0.16
14.95%
1M
-0.86
48.59%
6M
-0.98
51.85%
YTD
-2.47
73.08%
1Y
-1.58
63.38%
3Y
-19.37
95.51%
5Y
-61.73
98.55%
10Y
-61.73
98.55%
20Y
Nasdaq,
Closing price Wed, Oct 07 2026
-0.02
2.15%
Powered by
ISIN
US0310941051
Symbol
AMST
Index
Sector
Industry
Is Amesite Operating Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.
Key metrics
Basic
Market capitalization
$6.1m
Enterprise Value
$3.8m
Net debt
positive
Cash
$2.3m
Shares outstanding
6.6m
Valuation
P/E
negative
P/S | estimate
16.9 | -
EV/Sales | estimate
10.5 | -
EV/FCF | ex SBC
negative | -
P/B
2.3
Financial Health
Equity Ratio
87.6%
Return on Equity
-116.7%
ROCE
-118.6%
ROIC
-
Debt/Equity
0.0
Amesite Operating Co Stock Analysis
Unlock Scores for Free
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Buy
86%
Hold
14%
Don't miss a Thing! We will send you all news about Amesite Operating Co directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Amesite Operating Co Stock News
Neutral
GlobeNewsWire
●
14 days ago
Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations Company Estimates Agreements at New Pricing Level Can Generate Approximately 85% Gross Margin, Supporting Scalable Growth Across Post-Acute Care Organizations
Neutral
GlobeNewsWire
●
5 months ago
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
Neutral
GlobeNewsWire
●
5 months ago
$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants $2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants
Company Profile
Amesite, Inc. is a development stage artificial intelligence software company. The company is headquartered in Detroit, MI.
| Head office | United States |
| CEO | Dr. Sastry |
| Employees | 6 |
| Founded | 2017 |
| Website | amesite.com |


